Related Experiment Video
Updated: May 10, 2026
05:08
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Targeting aneuploidy for cancer therapy
Eusebio Manchado1, Marcos Malumbres
1Cell Division and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
Cell
|February 22, 2011
Summary
Aneuploid cells, common in tumors, are highly sensitive to proteotoxic and energy stress. This vulnerability may pave the way for novel cancer therapies targeting these specific cellular weaknesses.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Tumor cells often exhibit aneuploidy, an abnormal chromosome number.
- Aneuploidy is a hallmark of many cancers, contributing to genomic instability.
Discussion:
- Aneuploid cells demonstrate heightened sensitivity to compounds inducing proteotoxic stress.
- These cells are also vulnerable to agents causing energy stress.
- This dual sensitivity suggests a potential therapeutic window.
Key Insights:
- Aneuploid cancer cells are selectively vulnerable to proteotoxic and energy stress.
- This finding links chromosomal instability to metabolic and protein homeostasis vulnerabilities.
- Targeting these stress pathways could offer a novel anti-cancer strategy.
Outlook:
- Exploiting aneuploid cell sensitivity could lead to new targeted cancer therapies.
- Further research is needed to identify specific compounds and therapeutic regimens.
- This approach may offer a way to selectively eliminate tumor cells while sparing normal cells.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...